Search clinical trials for: Peripheral blood lymphocyte subsets
Total 140974 results
-
Cancer Institute and Hospital, Chinese Academy...RecruitingLocally Advanced Non-small Cell Lung CancerChina
-
Yanfeng HouRecruiting
-
Nanfang Hospital of Southern Medical UniversityNot yet recruitingNephrotic Syndrome | Lymphocyte Disorder
-
Shanghai Cancer Hospital, ChinaRecruitingNSCLC | Thymic Epithelial Tumor | Esophageal Squamous Cell CarcinomaChina
-
Sichuan Cancer Hospital and Research InstituteNot yet recruitingSurgery | Neoadjuvant Therapy | Esophageal Squamous Cell CarcinomaChina
-
San Salvatore Hospital of L'AquilaCompletedCovid19 | Acute Respiratory Distress Syndrome | Ventilatory FailureItaly
-
Centre Leon BerardAmgenTerminated
-
Bristol-Myers SquibbRecruitingPeripheral T-cell LymphomaJapan
-
Yanyan LiuRecruiting
-
Essen BiotechNot yet recruitingT Cell Lymphoma | T Cell Prolymphocytic Leukemia | T-cell Acute Lymphoblastic Leukemia | T Cell Leukemia | T-Cell Lymphoma of CNS | T Cell Childhood ALLChina
-
Sohag UniversityNot yet recruiting
-
Sun Yat-sen UniversityRecruitingExtranodal NK/T-cell LymphomaChina
-
Arvinas Inc.RecruitingRelapsed/Refractory (R/R) Mature B Cell Non Hodgkin Lymphoma (NHL) | Relapsed/Refractory (R/R) Angioimmunoblastic T-cell Lymphoma (AITL)United States, Spain
-
St. Jude Children's Research HospitalAbbVieNot yet recruitingT-cell Lymphoma | T-cell Acute Lymphoblastic Leukemia | Mixed Phenotype Acute LeukemiaUnited States
-
Beijing GoBroad HospitalNot yet recruitingAcute Lymphoblastic Leukemia, in Relapse | B-cell Acute Lymphoblastic Leukemia | Refractory Acute Lymphoid LeukemiaChina
-
Boston Immune Technologies and TherapeuticsNot yet recruitingPeripheral T-cell Lymphoma | NHL | Cutaneous T Cell Lymphoma
-
Instituto de Investigación Biomédica de SalamancaCarlos III Health InstituteRecruitingCutaneous T-Cell LymphomaSpain
-
Beijing Tongren HospitalRecruitingT-lymphoblastic Lymphoma | Natural Killer/T-Cell Lymphoma, Nasal and Nasal-TypeChina
-
University of AarhusAarhus University HospitalRecruitingPeripheral T-cell Lymphoma | NK/T-Cell LymphomaDenmark
-
Fudan UniversityRecruitingNatural Killer/T-Cell Lymphoma, Nasal and Nasal-TypeChina
-
Ruijin HospitalNot yet recruiting
-
Seagen Inc.RecruitingLymphoma, Large B-Cell, Diffuse | Hodgkin Disease | Lymphoma, T-Cell, Peripheral | Lymphoma, Large-Cell, AnaplasticUnited States
-
Qiu LuguiRecruitingDiffuse Large B-cell Lymphoma | Peripheral T Cell LymphomaChina
-
Huijing WuBeijing Xisike Clinical Oncology Research Foundation; CSPC Pharmaceutical GroupRecruitingAngioimmunoblastic T-cell LymphomaChina
-
BGI, ChinaShenzhen University General HospitalRecruiting
-
The First Affiliated Hospital with Nanjing Medical...Recruiting
-
Baylor College of MedicineThe Methodist Hospital Research Institute; Center for Cell and Gene Therapy...Not yet recruitingHodgkin Lymphoma | Non-Hodgkin Lymphoma | Peripheral T-cell Lymphoma | Anaplastic Large Cell Lymphoma, ALK-Positive | Anaplastic Large Cell Lymphoma, ALK-negative | CD30-Positive Diffuse Large B-Cell Lymphoma | Anaplastic Large Cell Lymphoma, T Cell and Null Cell TypeUnited States
-
Navy General Hospital, BeijingChinese PLA General HospitalRecruitingRelapsed Angioimmunoblastic T-Cell Lymphoma | Refractory Angioimmunoblastic T-cell LymphomaChina
-
Jiangsu HengRui Medicine Co., Ltd.RecruitingPeripheral T-cell LymphomaChina
-
National Institute for Mother and Child Health...Marie Curie Emergency Children's Hospital, Bucharest; Victor Gomoiu Children...RecruitingChronic Granulomatous DiseaseRomania
-
National Cancer Centre, SingaporeMerck Sharp & Dohme LLC; National Medical Research Council (NMRC), SingaporeNot yet recruitingRefractory Peripheral T-Cell Lymphoma | Relapsed Peripheral T-Cell LymphomaSingapore
-
University of Kansas Medical CenterNational Cancer Institute (NCI); Iovance Biotherapeutics, Inc.RecruitingMetastatic Melanoma | Unresectable Melanoma | Pathologic Stage IIIC Cutaneous Melanoma AJCC v8 | Clinical Stage IV Cutaneous Melanoma AJCC v8United States
-
The First Affiliated Hospital of Xiamen UniversityThe First Affiliated Hospital with Nanjing Medical University; Shanxi Province... and other collaboratorsRecruitingPeripheral T Cell Lymphoma | Relapsed Peripheral T-Cell Lymphoma | Refractory T-Cell LymphomaChina
-
Children's Hospital Medical Center, CincinnatiRecruitingLymphoma | Follicular Lymphoma | Leukemia | B Cell Lymphoma | Hodgkin Lymphoma | Burkitt Lymphoma | AML | Non Hodgkin Lymphoma | Acute Lymphocytic Leukemia | Acute Myelogenous Leukemia | Diffuse Large B Cell Lymphoma | Hematologic Malignancy | Chronic Myelogenous Leukemia | Myeloproliferative Neoplasm | T-cell Lymphoma | Peripheral T Cell Lymphoma and other conditionsUnited States
-
Jiangsu HengRui Medicine Co., Ltd.RecruitingRelapsed/Refractory PTCLT With at Least One Line of Prior Systemic TherapyChina
-
Seagen Inc.RecruitingLymphoma, Large B-Cell, Diffuse | Lymphoma, Non-Hodgkin | Hodgkin Disease | Lymphoma, T-Cell, Cutaneous | Lymphoma, T-Cell, Peripheral | Lymphoma, Large-Cell, AnaplasticUnited States
-
Fondazione Italiana Linfomi - ETSNot yet recruitingCutaneous T Cell Lymphoma | Cutaneous T-Cell Lymphoma/Mycosis Fungoides | Cutaneous T-Cell Lymphoma/Sezary SyndromeItaly
-
Centre Henri BecquerelNot yet recruitingPeripheral T Cell LymphomaFrance
-
Peking Union Medical College HospitalRecruitingPeripheral T Cell LymphomaChina
-
Acrotech Biopharma Inc.RecruitingPeripheral T Cell LymphomaUnited States
-
Ruijin HospitalNot yet recruitingNK-T-Cell Lymphoma, ExtranodalChina
-
Kathleen DorritieBristol-Myers SquibbRecruitingRelapsed and Refractory Multiple MyelomaUnited States
-
Peking Union Medical College HospitalRecruitingCutaneous T-cell LymphomaChina
-
Bristol-Myers SquibbRecruitingRelapsed or Refractory T-cell LymphomasJapan
-
Xin-Hua XuRecruitingHepatocellular CarcinomaChina
-
Yale UniversityKyowa Kirin, Inc.Not yet recruitingT Cell LymphomaUnited States
-
University of Southern CaliforniaNational Cancer Institute (NCI)Not yet recruitingTriple Negative Breast CancerUnited States
-
University of Alabama at BirminghamNot yet recruiting
-
Zhao WeiliNot yet recruiting